Shares of Catalent Inc (NYSE:CTLT) ended Friday session in green amid volatile trading. The shares closed up +0.07 points or 0.26% at $26.70 with 4.13 million shares getting traded. Post opening the session at $26.68, the shares hit an intraday low of $26.44 and an intraday high of $26.83 and the price vacillated in this range throughout the day. The company has a market cap of $3.35 billion and the numbers of outstanding shares have been calculated to be 124.74 million shares.
Catalent Inc (CTLT) on September 13, 2016 announced an agreement for Catalent, through its wholly owned subsidiary, Catalent Pharma Solutions, Inc., to acquire Pharmatek Laboratories, Inc., a West Coast, U.S.-based specialist in drug development and clinical manufacturing. The acquisition will add extensive early-phase drug development capabilities from discovery to clinic, bring spray drying into Catalent’s portfolio of drug formulation and delivery technologies, and expand Catalent’s capability for handling highly potent compounds. The addition of spray drying will also provide Catalent customers with a comprehensive suite of bioavailability enhancement solutions, while complementing and expanding Catalent’s OptiForm® Solution Suite platform, a science-driven parallel screening approach to identify the optimal formulation pathway for poorly soluble compounds. No financial details have been disclosed.
Founded in 1999, Pharmatek provides dosage form development and clinical-scale cGMP manufacturing of oral, injectable and topical products for more than 100 customers globally. At its San Diego facility, Pharmatek offers a fully integrated drug development platform, with discovery formulation screening for lead selection and optimization, comprehensive formulation development and analytical services, and finished dose form manufacturing for clinical supply. Additional services include first-in-man strategies, solutions for poorly soluble compounds, controlled release formulations, and specialized facilities and controls for potent compound handling.
Shares of EnteroMedics Inc (NASDAQ:ETRM) ended Friday session in red amid volatile trading. The shares closed down -0.005 points or -3.56% at $0.133 with 4.12 million shares getting traded. Post opening the session at $0.14, the shares hit an intraday low of $0.13 and an intraday high of $0.14 and the price vacillated in this range throughout the day. The company has a market cap of $9.46 million and the numbers of outstanding shares have been calculated to be 69.70 million shares.
EnteroMedics Inc (ETRM) announced that it will present at the Ladenburg Thalmann Healthcare Conference at the Sofitel New York Hotel on Tuesday, September 27, 2016 at 4:00 p.m. ET.